Vida Ventures related stories
All articles and analysis
Boston Therapeutics rakes in $150m Series CFrazier Life Sciences and Lightspeed Venture Partners led the round.
- Vida Ventures raises $825m for third fund
Vida Ventures has closed its third fund at $825 million.
Side Letter: Leonard Green's mega-GP-led; another OMERS PE departureLeonard Green & Partners has closed one of the largest GP-led deals ever. Plus: Highlights from yesterday's AVCA conference and another departure from OMERS PE. Here's today's brief, for our valued subscribers only.
Texas County confirms $75m commitmentThe US public pension fund has backed Vida Venture's third vehicle, which is targeted at $750m.
Vida Ventures targets $750m for latest fundThe Boston-based fund manager launches its latest venture capital and growth equity vehicle.
TCDRS confirms $75m commitmentThe US public pension fund has backed Vida Venture's third biotech and life-science vehicle.
Vida Ventures targets $750m for third fundVida Ventures is seeking to raise $750 million for its third fund, according to an SEC filing.
- Centessa Pharmaceuticals reels in $250m Series A
Centessa Pharmaceuticals, a drug developer, has raised $250 million in Series A financing.
Scorpion Therapeutics picks up $162m Series BScorpion Therapeutics, Inc., a next-generation precision oncology company, has raised $162 million in Series B financing.
- IconOVir Bio snags $77m Series A
IconOVir Bio Inc., a preclinical-stage biotechnology company, has raised $77 million in Series A financing.